Sagimet Biosciences, Inc. (SGMT)
9.45
+0.33
(+3.62%)
USD |
NASDAQ |
Nov 06, 10:30
Sagimet Biosciences Market Cap : 583.85M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 563.46M |
| November 04, 2026 | 617.21M |
| November 03, 2026 | 614.74M |
| November 02, 2026 | 598.68M |
| October 30, 2026 | 612.89M |
| October 29, 2026 | 644.40M |
| October 28, 2026 | 663.55M |
| October 27, 2026 | 643.78M |
| October 26, 2026 | 590.64M |
| October 23, 2026 | 591.88M |
| October 22, 2026 | 614.74M |
| October 21, 2026 | 617.21M |
| October 20, 2026 | 601.77M |
| October 19, 2026 | 547.40M |
| October 16, 2026 | 495.50M |
| October 15, 2026 | 504.77M |
| October 14, 2026 | 466.15M |
| October 13, 2026 | 493.03M |
| October 12, 2026 | 543.69M |
| October 09, 2026 | 551.72M |
| October 08, 2026 | 551.10M |
| October 07, 2026 | 548.63M |
| October 06, 2026 | 541.22M |
| October 05, 2026 | 557.90M |
| October 02, 2026 | 564.70M |
| Date | Value |
|---|---|
| October 01, 2026 | 578.91M |
| September 30, 2026 | 610.42M |
| September 29, 2026 | 576.43M |
| September 28, 2026 | 614.12M |
| September 25, 2026 | 570.87M |
| September 24, 2026 | 562.84M |
| September 23, 2026 | 643.78M |
| September 22, 2026 | 685.17M |
| September 21, 2026 | 667.26M |
| September 18, 2026 | 685.17M |
| September 17, 2026 | 690.12M |
| September 16, 2026 | 646.25M |
| September 15, 2026 | 646.25M |
| September 14, 2026 | 672.20M |
| September 11, 2026 | 672.20M |
| September 10, 2026 | 683.32M |
| September 09, 2026 | 670.96M |
| September 08, 2026 | 661.69M |
| September 04, 2026 | 675.90M |
| September 03, 2026 | 674.67M |
| September 02, 2026 | 678.99M |
| September 01, 2026 | 648.72M |
| August 31, 2026 | 633.89M |
| August 28, 2026 | 651.81M |
| August 27, 2026 | 664.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 226.76M |
| IDEAYA Biosciences, Inc. | 2.998B |
| ACADIA Pharmaceuticals, Inc. | 3.586B |
| Alnylam Pharmaceuticals, Inc. | 21.22B |
| Anika Therapeutics, Inc. | 211.85M |
Market Cap Related Metrics
| Price to Book Value | 2.279 |
| Price | 9.45 |
| Earnings Yield | -13.56% |